Definitive Healthcare Corp.

Definitive Healthcare Corp.

DH
Definitive Healthcare Corp.US flagNASDAQ Global Select
1.01
USD
- -
- -
106.58MMarket Cap
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
1.35
1.81
2.2
2.23
2.16
2.26
2.23
Basic EPS, GAAP
- -
-0.6
-0.56
-0.07
-1.79
-3.54
-1.3
-1.61
Free Cash Flow per Basic Share
- -
0.25
0.2
0.27
0.34
0.39
0.35
0.27
Dividend per Share
- -
0.03
0.09
0.13
0.11
- -
- -
- -
Book Value per Share
13.9
13.66
8.98
9.03
7.39
3.9
2.7
1.36
Tangible Book Value per Share
-5.29
-5.44
-7.67
-6.91
-4.61
-2.17
-1.57
-0.73
Basic Weighted Avg Shares
- -
88
92
101
113
117
107
104
Sales/Revenue/Turnover
- -
118
166
223
251
252
242
233
Operating Margin (%)
- -
-10.24
-12.66
-16.24
-12.29
-3.86
-8.52
-8.45
Depreciation Expense
- -
60
60
57
52
52
56
55
Net Income, GAAP
- -
-53
-52
-7
-202
-413
-139
-168
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
-44.46
-31.24
-3.24
-80.5
-163.81
-57.52
-72.28
Working Capital
-34
-25
321
273
223
209
101
111
LT Debt
435
457
264
266
252
237
161
156
Total Equity
1,216
1,196
1,500
1,482
1,199
607
379
188
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
-4.36
-5.02
-0.79
-22.36
-63.28
-38.3
-75.04

Capital Structure

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
11
11
11
LT Borrowings
156
154
152
LT Finance Leases
5
4
4
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
104
105
106
Market Capitalization
299
129
88

Working Capital

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
258
246
240
Cash, Cash Equivalents & STI
181
178
184
Accounts Receivable, Net
53
40
31
Inventories
- -
- -
- -
Total Current Liabilities
157
140
129
Payables & Accruals
42
25
24
ST Debt
11
11
11
Deferred Revenue
97
99
89

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-16.35%
-37.58%
Free Cash Flow
- -
14.64%
-19.18%
Net Income, GAAP
- -
530.55%
-66.37%
Sales/Revenue/Turnover
- -
16.68%
-4.24%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
63
64
63
62
252
2025
59
61
60
62
242
2026
56
55
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.08
-1.81
-1.12
-0.51
-3.54
2025
-1.02
-0.07
-0.14
-0.09
-1.3
2026
-1.32
-0.05
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Kevin D. Coop
Full Time Employees
682
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Address
492 Old Connecticut Path Framingham MA United States of America 01701
IPO Date
Sep 15, 2021
Business
Definitive Healthcare Corp. Definitive Healthcare Corp. (DH) provides software-as-a-service (SaaS) healthcare commercial intelligence through a platform that transforms data, analytics, and expertise into actionable insights for biopharma, medtech, healthcare providers, software and IT firms, and professional services; the platform features 16 intelligence modules covering sales intelligence, marketing optimization, clinical research and product development, strategy, talent acquisition, market planning, go-to-market strategies, healthcare provider affiliations, medical claims data, IDN hierarchies, RFP processes, physician prescribing habits, population health data, custom reporting, mapping, and CRM integrations. Founded in 2011 and headquartered in Framingham, Massachusetts, the company operates primarily in the United States with additional locations in Sweden and India, deriving substantially all revenue from subscription fees and support services. Recent developments include a strategic data partnership with a $10 million CapEx investment in 2024, refinancing of debt to a $175 million term loan and $50 million revolving facility extending to 2030, integration of med device sales into the biopharma team, alignment of customer success teams with sales incentives, and investments in AI-powered tools for physician analysis and enterprise customer growth driving raised 2025 revenue and profit guidance.

Company News

  • Financial Review: HealthStream (NASDAQ:HSTM) versus Definitive Healthcare (NASDAQ:DH)

  • Special Committee of Definitive Healthcare Board Confirms Receipt of Going-Private Proposal from Advent International

  • Definitive Healthcare Appoints Clay Ritchey as CEO

  • Definitive Healthcare (NASDAQ:DH) & Certara (NASDAQ:CERT) Financial Comparison

  • Definitive Healthcare Corp. (NASDAQ:DH) Given Consensus Rating of “Reduce” by Analysts

  • Definitive Healthcare Corp. (DH) Q2 2026 Earnings Call Transcript

  • Definitive Healthcare Corp. (DH) Q2 Earnings Surpass Estimates

  • Definitive Healthcare Q2 Earnings Call Highlights

  • Definitive Healthcare Launches Early Adopter Program for New AI-Powered Healthcare Intelligence Platform

  • Definitive Healthcare Announces Timing of Its Second Quarter 2026 Financial Results Conference Call and Webcast

  • Analysts Estimate Definitive Healthcare Corp. (DH) to Report a Decline in Earnings: What to Look Out for

  • Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)

  • Restaurant365 Names Kate Hastings Chief Customer Officer as It Expands Investment in Customer Success

  • Definitive Healthcare advances data platform and integrations to deliver smarter healthcare insights

  • Definitive Healthcare advances data platform and integrations to deliver smarter healthcare insights

  • Definitive Healthcare Corp. (DH) Q1 2026 Earnings Call Transcript

  • Definitive Healthcare Corp. (DH) Tops Q1 Earnings Estimates

  • Definitive Healthcare Reports Financial Results for First Quarter 2026

  • Analysts Estimate Definitive Healthcare Corp. (DH) to Report a Decline in Earnings: What to Look Out for

  • Definitive Healthcare Announces Timing of Its First Quarter 2026 Financial Results Conference Call and Webcast